BeStock  
Stocks › SHTDY

SINOPHARM GROUP CO SHTDY

US equityMarket cap rank #1889
$10.65 −$0.05 (-0.47%)
Market closed · Nov 22, 9:30 am ET
Open$10.67
Prev close$10.70
Day range$10.62 – $10.69
Volume13.5K
Market cap$5.84B
P/E (TTM)6.6
Dividend yield4.72%

SHTDY Stock News

Headlines matching SINOPHARM GROUP CO or the SHTDY ticker, most recent first.

  • Sinopharm Shares: Legal Opinion of Beijing Guofeng Law Firm Regarding the Third Extraordinary Shareholders' Meeting of Sinopharm Group Pharmaceutical Co., Ltd. for 2026SZSI · 5 Sep 2026 · Related
  • Lazard Asset Management LLC reduced its stake in Sinopharm Group Holding (01099) by 738,800 shares at approximately HK$15.1 per share.Zhitong Finance · 27 Sep 2026 · Related
  • FMR LLC reduced its stake in Sinopharm Group Co., Ltd. (01099) by 732,400 shares at approximately HK$15.01 per share.Zhitong Finance · 27 Sep 2026 · Related
  • Sinopharm Modern (600420.SH): Exports of penicillin-type pharmaceutical intermediates and active pharmaceutical ingredients are primarily directed to Asian countries such as India, South Korea, and Thailand.Gelonghui Finance · 24 Sep 2026 · Related
  • JiQiang Bio: Risk Disposal Plan for Conducting Deposit, Loan, and Other Financial Services at Sinopharm Group Finance Co., Ltd.SZSI · 2 Sep 2026 · Related
  • Jiqiang Bio: Report on the Ongoing Risk Assessment of Sinopharm Group Finance Co., Ltd.SZSI · 2 Sep 2026 · Related
  • JiQiang Bio: Announcement Regarding the Proposed Renewal of the Financial Services Agreement with Sinopharm Group Finance Co., Ltd. and Related Party TransactionsSZSI · 2 Sep 2026 · Related
  • Sinopharm Group Co., Ltd.: 000028 Sinopharm Group Investor Relations Management Information, September 18, 2026SZSI · 18 Sep 2026 · Related
  • Sinopharm Group (01099) elects Jin Bin as Chairman of the Board.Zhitong Finance · 15 Sep 2026 · Related
  • Sinopharm Group (01099.HK) saw its H-share holdings increased by Lazard Asset Management LLC by 959,600 shares, valued at approximately HK$15.04 million.Market news · 10 Sep 2026 · Related
  • Jiuqiang Biology (300406.SZ): Plans to Renew the Financial Services Agreement with Sinopharm Group Finance Co., Ltd.Gelonghui Finance · 1 Sep 2026 · Related
  • Sinopharm Group Co., Ltd. (000028): Amid Pressure on Distribution and Retail, the Retail Business Continues to ImproveHuatai Securities · 29 Aug 2026 · Related
  • Sinopharm Group Co., Ltd. (600511): Parent Company Demonstrates Steady Growth; H2 Growth Expected to Accelerate PositiveChina Securities Co., Ltd. · 28 Aug 2026 · Related
  • Sinopharm Holdings (01099.HK): Results in line with expectations; the retail segment continues to grow rapidly.CICC · 25 Aug 2026 · Related
  • Sinopharm Group (01099) proposes the re-election of Lian Wanyong as an executive director of the seventh board of directors.Zhitong Finance · 24 Aug 2026 · Related

Discussion

No comments yet — be the first to weigh in on SHTDY.

Sign in to join the discussion.

Scroll to Top